Establishing a HTS workflow for cell cultivation, lysis and analytics.
Optimizing the production of recombinant virus-like particles for chimeric vaccines.
Yielding 1.63 mg/mL VP1 with 43% TSP by codon optimization and design of experiments.
Developing a simple two-step downstream process for murine polyomavirus protein VP1.
Assembling VP1 into homogeneous VLPs with a size of 40–50 nm and a protein purity of 92%.